Submitted by endpointsnews6292 in news

Vertex and CRISPR Therapeutics have won the first-ever approval for a therapy created with CRISPR gene editing, as the UK drug regulator MHRA greenlights their treatment for two blood disorders. The therapy previously known as exa-cel will now be branded Casg…

55

Comments

You must log in or register to comment.

There's nothing here…